使 - -

Luke V Selby1,2, Emma Clark3,4, James L Chen5

  • 1Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.

PubMed
概括

乳腺血管瘤的新辅助剂帕克利塔塞尔 (NAC) 显示出实现负手术边缘和完整的病理反应的前景. 然而,目前的数据不显示对整体存活率的影响,需要进一步研究.